• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道胰腺神经内分泌肿瘤的临床病理研究:单机构经验

Clinicopathologic study of neuroendocrine tumors of gastroenteropancreatic tract: a single institutional experience.

作者信息

Uppin Megha S, Uppin Shantveer G, Sunil Chittiboyina Shiva Prasada Venkata, Hui Monalisa, Paul Tara Roshni, Bheerappa Nagari

机构信息

Department of Pathology, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana 500082, India.

Department of Surgical Gastroenterology, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana 500082, India.

出版信息

J Gastrointest Oncol. 2017 Feb;8(1):139-147. doi: 10.21037/jgo.2016.12.08.

DOI:10.21037/jgo.2016.12.08
PMID:28280618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5334039/
Abstract

BACKGROUND

The gastroenteropancreatic neuroendocrine tumors (GEPNET) have a characteristic histologic appearance unrelated of the exact site of origin. However the behavior of these tumors are different in each of these sites. In this article we study the clinicopathological features of GEPNET. These tumors were classified and graded according to WHO 2010 criteria. The immunohistochemical (IHC) features were evaluated and the grade of the tumor was correlated with Ki67.

METHODS

A total of 40 cases of GEPNET diagnosed on biopsies as well as resected specimens were analyzed from January 2012 to June 2015.

RESULTS

There were 28 resected specimens and 12 biopsies. Majority of the gastric neuroendocrine tumors (NET) showed classic morphology of cells arranged in islands. There were 3 cases each of grade 1 and grade 2 and one was diagnosed as mixed adenoneuroendocrine carcinoma (MANEC). All the duodenal NET were well differentiated (grade 1). There were 8 cases in colon and rectum, of which 4 cases were grade 3 and 3 cases were grade 2. Majority of the pancreatic tumors were grade 1. The mean mitotic count along with ki67 had good correlation in NET of stomach, duodenum colon and rectum.

CONCLUSIONS

The most common site was small intestine followed by pancreas. Majority of the tumors were NET G1. Tumors from colorectal region were mostly NEC G3. There was a strong correlation by spearman correlation analysis between Ki67 and mitotic count and moderate correlation between ki67 and tumor grade as well as mitotic rate and tumor grade. Ki67 was helpful in grading these tumors.

摘要

背景

胃肠胰神经内分泌肿瘤(GEPNET)具有独特的组织学表现,与确切的起源部位无关。然而,这些肿瘤在每个部位的行为有所不同。在本文中,我们研究了GEPNET的临床病理特征。这些肿瘤根据世界卫生组织2010年标准进行分类和分级。评估了免疫组化(IHC)特征,并将肿瘤分级与Ki67进行了关联分析。

方法

分析了2012年1月至2015年6月间经活检及手术切除标本确诊的40例GEPNET病例。

结果

有28例手术切除标本和12例活检标本。大多数胃神经内分泌肿瘤(NET)表现出典型的细胞呈岛状排列的形态。1级和2级各有3例,1例被诊断为混合性腺神经内分泌癌(MANEC)。所有十二指肠NET均为高分化(1级)。结肠和直肠有8例,其中4例为3级,3例为2级。大多数胰腺肿瘤为1级。胃、十二指肠、结肠和直肠NET的平均有丝分裂计数与Ki67具有良好的相关性。

结论

最常见的部位是小肠,其次是胰腺。大多数肿瘤为NET G1。结直肠区域的肿瘤大多为NEC G3。Spearman相关性分析显示,Ki67与有丝分裂计数之间存在强相关性,Ki67与肿瘤分级以及有丝分裂率与肿瘤分级之间存在中度相关性。Ki67有助于这些肿瘤的分级。

相似文献

1
Clinicopathologic study of neuroendocrine tumors of gastroenteropancreatic tract: a single institutional experience.胃肠道胰腺神经内分泌肿瘤的临床病理研究:单机构经验
J Gastrointest Oncol. 2017 Feb;8(1):139-147. doi: 10.21037/jgo.2016.12.08.
2
Clinicopathologic profile of gastroenteropancreatic neuroendocrine neoplasms in a referral center of South India.印度南部一家转诊中心的胃肠胰神经内分泌肿瘤的临床病理特征
Int J Clin Exp Pathol. 2022 May 15;15(5):225-232. eCollection 2022.
3
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.胰腺WHO 3级(G3)高分化神经内分泌肿瘤(WD-NET)和低分化神经内分泌癌(PD-NEC)分类的实用方法
Am J Surg Pathol. 2016 Sep;40(9):1192-202. doi: 10.1097/PAS.0000000000000662.
4
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.高级别(世界卫生组织G3级)胰腺神经内分泌肿瘤类别在形态学和生物学上具有异质性,包括高分化和低分化肿瘤。
Am J Surg Pathol. 2015 May;39(5):683-90. doi: 10.1097/PAS.0000000000000408.
5
Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.世界卫生组织2000/2004年与世界卫生组织2010年胃肠道和胰腺神经内分泌肿瘤分类的比较。
Ann Diagn Pathol. 2015 Apr;19(2):81-7. doi: 10.1016/j.anndiagpath.2015.01.001. Epub 2015 Jan 9.
6
Clinicopathological Features of Primary Neuroendocrine Tumors of Gastrointestinal/Pancreatobiliary Tract With Emphasis on High-Grade (Grade 3) Well-Differentiated Neuroendocrine Tumors.胃肠道/胰胆管原发性神经内分泌肿瘤的临床病理特征,重点关注高级别(3级)高分化神经内分泌肿瘤。
Cureus. 2021 Jan 11;13(1):e12640. doi: 10.7759/cureus.12640.
7
The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.磷酸化组蛋白H3辅助有丝分裂计数和Ki67评分在高分化胰腺神经内分泌肿瘤的肿瘤分级判定及远处转移预测中的作用
Endocr Pathol. 2016 Jun;27(2):162-70. doi: 10.1007/s12022-016-9424-9.
8
A Case of Gastric Neuroendocrine Neoplasm with Mixed Grade: a Distinct Type of "High"-grade Well-Differentiated Neuroendocrine Neoplasm.混合级别胃神经内分泌肿瘤 1 例:一种独特类型的“高”级别高分化神经内分泌肿瘤。
Endocr Pathol. 2018 Sep;29(3):289-293. doi: 10.1007/s12022-018-9528-5.
9
Clinicopathological Features of Neuroendocrine Tumors in Gastroenteropancreatic Tract: A Single Center Study.胃肠道胰腺神经内分泌肿瘤的临床病理特征:一项单中心研究
Cureus. 2022 Jul 28;14(7):e27384. doi: 10.7759/cureus.27384. eCollection 2022 Jul.
10
[Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].240例胃神经内分泌肿瘤的临床病理特征及预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Jan 25;23(1):38-43. doi: 10.3760/cma.j.issn.1671-0274.2020.01.007.

引用本文的文献

1
Histopathological features of gastrointestinal and pancreatic neuroendocrine neoplasms: An 11-year retrospective study from a tertiary center in Saudi Arabia.胃肠道和胰腺神经内分泌肿瘤的组织病理学特征:来自沙特阿拉伯一家三级中心的11年回顾性研究。
Saudi Med J. 2025 Jul;46(7):761-767. doi: 10.15537/smj.2025.46.7.20250313.
2
Lymph node metastatic patterns of gastric carcinoma with a combination of adenocarcinoma and neuroendocrine carcinoma components.具有腺癌和神经内分泌癌成分组合的胃癌的淋巴结转移模式。
World J Gastroenterol. 2025 Feb 28;31(8):102347. doi: 10.3748/wjg.v31.i8.102347.
3
Ectopic gastric mucosa in the submucosa of the stomach: A case report.胃黏膜下层的异位胃黏膜:一例报告
Exp Ther Med. 2023 Oct 2;26(5):539. doi: 10.3892/etm.2023.12238. eCollection 2023 Nov.
4
Clinicopathological Features of Neuroendocrine Tumors in Gastroenteropancreatic Tract: A Single Center Study.胃肠道胰腺神经内分泌肿瘤的临床病理特征:一项单中心研究
Cureus. 2022 Jul 28;14(7):e27384. doi: 10.7759/cureus.27384. eCollection 2022 Jul.
5
Clinicopathologic profile of gastroenteropancreatic neuroendocrine neoplasms in a referral center of South India.印度南部一家转诊中心的胃肠胰神经内分泌肿瘤的临床病理特征
Int J Clin Exp Pathol. 2022 May 15;15(5):225-232. eCollection 2022.
6
Mixed adenoneuroendocrine carcinoma of the hepatic bile duct: a case report and review of the literature.肝内胆管混合性腺神经内分泌癌:病例报告及文献复习。
BMC Gastroenterol. 2020 Nov 25;20(1):399. doi: 10.1186/s12876-020-01550-2.
7
Neuroendocrine Carcinoma of Duodenum-an Uncommon Tumour at an Unusual Site.十二指肠神经内分泌癌——一个罕见部位的罕见肿瘤
Indian J Surg Oncol. 2019 Mar;10(1):199-203. doi: 10.1007/s13193-018-0834-7. Epub 2018 Dec 7.
8
Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin.不同来源的胃肠胰神经内分泌肿瘤中生长抑素和趋化因子受体 CXCR4 的表达不同。
Sci Rep. 2019 Mar 13;9(1):4339. doi: 10.1038/s41598-019-39607-2.
9
Combination of laparoscopy and endoscopy as an option for treatment patients with gastric neuroendocrine tumors.腹腔镜检查与内镜检查联合作为胃神经内分泌肿瘤患者的一种治疗选择。
J Surg Case Rep. 2019 Jan 31;2019(1):rjz007. doi: 10.1093/jscr/rjz007. eCollection 2019 Jan.

本文引用的文献

1
Neuroendocrine tumors of the luminal gastrointestinal tract.腔内胃肠道神经内分泌肿瘤
Arch Pathol Lab Med. 2015 Jun;139(6):750-6. doi: 10.5858/arpa.2014-0130-RA.
2
P53, KI-67, CD117 expression in gastrointestinal and pancreatic neuroendocrine tumours and evaluation of their correlation with clinicopathological and prognostic parameters.P53、KI-67、CD117在胃肠道及胰腺神经内分泌肿瘤中的表达及其与临床病理和预后参数的相关性评估
Turk J Gastroenterol. 2015 Mar;26(2):104-11. doi: 10.5152/tjg.2015.1965.
3
Prognostic significance of neuroendocrine components in gastric carcinomas.胃癌中神经内分泌成分的预后意义。
Eur J Cancer. 2014 Nov;50(16):2802-9. doi: 10.1016/j.ejca.2014.08.004. Epub 2014 Sep 4.
4
Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study.十二指肠和壶腹神经内分泌肿瘤的临床结果:一项基于人群的研究。
J Gastrointest Surg. 2014 Feb;18(2):354-62. doi: 10.1007/s11605-013-2365-4. Epub 2013 Oct 10.
5
Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence.胃肠道神经内分泌肿瘤分级系统的临床验证:WHO 2010 分类的 Ki67 指数标准适合预测转移或复发。
Diagn Pathol. 2013 Apr 22;8:65. doi: 10.1186/1746-1596-8-65.
6
Ki-67 is a reliable pathological grading marker for neuroendocrine tumors.Ki-67 是神经内分泌肿瘤可靠的病理分级标志物。
Virchows Arch. 2013 May;462(5):501-5. doi: 10.1007/s00428-013-1410-8. Epub 2013 Apr 16.
7
Comparison of methods for proliferative index analysis for grading pancreatic well-differentiated neuroendocrine tumors.比较用于分级胰腺高分化神经内分泌肿瘤的增殖指数分析方法。
Am J Clin Pathol. 2012 Apr;137(4):576-82. doi: 10.1309/AJCP92UCXPJMMSDU.
8
Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases.涉及胃肠胰神经内分泌肿瘤:773 例临床病理评估。
Clinics (Sao Paulo). 2011;66(10):1671-5. doi: 10.1590/s1807-59322011001000002.
9
Composite papillary intestinal-type adenocarcinoma/poorly differentiated neuroendocrine carcinoma of the ampulla of Vater.
J Clin Pathol. 2011 Feb;64(2):174-7. doi: 10.1136/jcp.2010.084954. Epub 2010 Nov 20.
10
A retrospective clinico-pathological analysis of neuroendocrine tumors of the gastrointestinal tract.胃肠道神经内分泌肿瘤的回顾性临床病理分析
Trop Gastroenterol. 2010 Apr-Jun;31(2):101-4.